cyclosporine

FDA Drug Profile — Neoral, Sandimmune, Cyclosporine, Restasis MultiDose, CYCLOSPORINE

cyclosporine is listed in the FDA National Drug Code directory with 28 NDC codes, marketed under brand names including Neoral, Sandimmune, Cyclosporine. Available dosage forms: solution, capsule, liquid filled, injection, emulsion, solution/ drops.

Drug Details

Generic Name
cyclosporine
Brand Names
Neoral, Sandimmune, Cyclosporine, Restasis MultiDose, CYCLOSPORINE, Verkazia, CEQUA, RESTASIS
Application Number
NDA050716
Sponsor
Novartis Pharmaceuticals Corporation
NDC Codes
28
Dosage Forms
SOLUTION, CAPSULE, LIQUID FILLED, INJECTION, EMULSION, SOLUTION/ DROPS
Routes
ORAL, INTRAVENOUS, OPHTHALMIC, TOPICAL
Active Ingredients
CYCLOSPORINE

Indications and Usage

1 INDICATIONS AND USAGE Cyclosporine ophthalmic emulsion, 0.05% is indicated to increase tear production in patients whose tear production is presumed to be suppressed due to ocular inflammation associated with keratoconjunctivitis sicca. Increased tear production was not seen in patients currently taking topical anti-inflammatory drugs or using punctal plugs. Cyclosporine ophthalmic emulsion, 0.05% is a calcineurin inhibitor immunosuppressant indicated to increase tear production in patients whose tear production is presumed to be suppressed due to ocular inflammation associated with keratoconjunctivitis sicca. Increased tear production was not seen in patients currently taking topical anti-inflammatory drugs or using punctal plugs. ( 1 )